Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
4,357 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | DASH | DoorDash, Inc. | Scotiabank | Initiated | — | Sector Outperform | Buy | 31 | $298.00 | +48.24% | 96.78B |
| Sep 9, 2026 | DECK | Deckers Outdoor Corporation | BMO Capital | Initiated | — | Underperform | — | — | $115.64 | +44.77% | 15.19B |
| Sep 9, 2026 | DEI | Douglas Emmett, Inc. | JP Morgan | Main | Neutral | Neutral | — | — | $15.00 | +40.58% | 1.97B |
| Sep 9, 2026 | DELL | Dell Technologies Inc. | Evercore ISI Group | Main | Outperform | Outperform | Buy | 19 | $161.75 | -68.08% | 93.2B |
| Sep 9, 2026 | DKS | DICK'S Sporting Goods, Inc. | BMO Capital | Initiated | — | Underperform | — | — | $239.64 | +79.99% | 17.55B |
| Sep 9, 2026 | DYN | Dyne Therapeutics, Inc. | Baird | Main | Outperform | Outperform | — | — | $38.11 | +106.89% | 2.77B |
| Sep 9, 2026 | DYN | Dyne Therapeutics, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $38.11 | +106.89% | 2.77B |
| Sep 9, 2026 | EBS | Emergent BioSolutions Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $51.50 | +777.34% | 633.13M |
| Sep 9, 2026 | EFSI | Eagle Financial Services, Inc. | DA Davidson | Main | Neutral | Neutral | — | — | $40.00 | -12.40% | 213.17M |
| Sep 9, 2026 | ENGN | enGene Holdings Inc. | Citizens | Reiterated | Market Perform | Market Perform | — | — | $22.67 | +1180.79% | 455.64M |
| Sep 9, 2026 | EPR | EPR Properties | JP Morgan | Main | Overweight | Overweight | Hold | 17 | $54.00 | -8.98% | 3.79B |
| Sep 9, 2026 | ETOR | eToro Group Ltd. | Goldman Sachs | Main | Neutral | Neutral | — | — | $61.50 | +104.86% | 3.28B |
| Sep 9, 2026 | EVMN | Evommune, Inc. | Leerink Partners | Main | Outperform | Outperform | — | — | $39.33 | +272.44% | 261.72M |
| Sep 9, 2026 | EVMN | Evommune, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $39.33 | +272.44% | 261.72M |
| Sep 9, 2026 | EVMN | Evommune, Inc. | HC Wainwright & Co. | Reiterated | Neutral | Neutral | — | — | $39.33 | +272.44% | 261.72M |
| Sep 9, 2026 | EXP | Eagle Materials Inc. | Wells Fargo | Downgrade | Overweight | Equal-Weight | Hold | 16 | $239.50 | +30.33% | 7.39B |
| Sep 9, 2026 | FCX | Freeport-McMoRan Inc. | Bernstein | Main | Market Perform | Market Perform | Buy | 15 | $48.10 | -32.47% | 69.08B |
| Sep 9, 2026 | FDX | FedEx Corporation | Evercore ISI Group | Main | In-Line | In-Line | Buy | 19 | $266.50 | -14.53% | 67.16B |
| Sep 9, 2026 | FELE | Franklin Electric Co., Inc. | DA Davidson | Main | Neutral | Neutral | Buy | 11 | $112.00 | +15.30% | 4.32B |
| Sep 9, 2026 | FENC | Fennec Pharmaceuticals Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $14.00 | +23.89% | 206.35M |
| Sep 9, 2026 | FHI | Federated Hermes, Inc. | Evercore ISI Group | Main | Outperform | Outperform | — | — | $51.00 | -16.38% | 4.07B |
| Sep 9, 2026 | FIGR | Figure Technology Solutions, Inc. Class A Common Stock | B of A Securities | Upgrade | Underperform | Neutral | Buy | 14 | $48.29 | +32.05% | 7.41B |
| Sep 9, 2026 | FLNC | Fluence Energy, Inc. | Piper Sandler | Initiated | — | Underweight | — | — | $15.75 | +62.54% | 3.39B |
| Sep 9, 2026 | FSLR | First Solar, Inc. | Piper Sandler | Initiated | — | Overweight | Buy | 47 | $276.34 | +33.39% | 29.27B |
| Sep 9, 2026 | GAP | The Gap, Inc. | BMO Capital | Initiated | — | Market Perform | — | — | $27.60 | +31.99% | 9.94B |
| Sep 9, 2026 | GEMI | Gemini Space Station, Inc. Class A Common Stock | Goldman Sachs | Main | Sell | Sell | — | — | $27.00 | +515.03% | 638.98M |
| Sep 9, 2026 | GH | Guardant Health, Inc. | UBS | Main | Buy | Buy | — | — | $93.00 | -41.52% | 12.58B |
| Sep 9, 2026 | GLUE | Monte Rosa Therapeutics, Inc. | Wedbush | Reiterated | Outperform | Outperform | — | — | — | — | 1.08B |
| Sep 9, 2026 | GPCR | Structure Therapeutics Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | $91.67 | +131.78% | 3.88B |
| Sep 9, 2026 | GRAL | GRAIL, Inc. | UBS | Initiated | — | Buy | — | — | $92.50 | +19.26% | 3.32B |
| Sep 9, 2026 | GWRE | Guidewire Software, Inc. | DA Davidson | Main | Buy | Buy | Buy | 21 | $275.00 | +96.30% | 17.39B |
| Sep 9, 2026 | HASI | HA Sustainable Infrastructure Capital, Inc. | Mizuho | Main | Outperform | Outperform | — | — | $48.50 | +28.96% | 4.17B |
| Sep 9, 2026 | HD | The Home Depot, Inc. | Bernstein | Main | Market Perform | Market Perform | Buy | 24 | $405.07 | +32.51% | 355.8B |
| Sep 9, 2026 | HOOD | Robinhood Markets, Inc. | StoneX | Initiated | — | Buy | Buy | 22 | $149.73 | +32.12% | 109.21B |
| Sep 9, 2026 | HOOD | Robinhood Markets, Inc. | Bernstein | Reiterated | Outperform | Outperform | Buy | 22 | $149.73 | +32.12% | 109.21B |
| Sep 9, 2026 | HOOD | Robinhood Markets, Inc. | Mizuho | Main | Outperform | Outperform | Buy | 22 | $149.73 | +32.12% | 109.21B |
| Sep 9, 2026 | HROW | Harrow Health, Inc. | Leerink Partners | Initiated | — | Outperform | — | — | $73.00 | +99.56% | 1.89B |
| Sep 9, 2026 | HROWL | Harrow Health, Inc. 8.625% Senior Notes due 2026 | Leerink Partners | Initiated | — | Outperform | — | — | — | — | 1.37B |
| Sep 9, 2026 | HROWM | Harrow Health, Inc. 11.875% Senior Notes due 2027 | Leerink Partners | Initiated | — | Outperform | Buy | 14 | $34.93 | +34.21% | 1.34B |
| Sep 9, 2026 | HTFL | Heartflow, Inc. Common Stock | UBS | Initiated | — | Neutral | — | — | $35.75 | -21.41% | 2.42B |
| Sep 9, 2026 | IDYA | IDEAYA Biosciences, Inc. | Guggenheim | Main | Buy | Buy | — | — | $42.43 | +13.30% | 2.94B |
| Sep 9, 2026 | IEX | IDEX Corporation | Oppenheimer | Main | Outperform | Outperform | Buy | 19 | $194.00 | -12.40% | 13.68B |
| Sep 9, 2026 | ILMN | Illumina, Inc. | UBS | Upgrade | Neutral | Buy | Hold | 28 | $115.25 | -42.74% | 20.84B |
| Sep 9, 2026 | ILMNV | Illumina, Inc. Common Stock Ex-distribution When-Issued | UBS | Upgrade | Neutral | Buy | — | — | — | — | 16.99B |
| Sep 9, 2026 | IMAX | IMAX Corporation | Rosenblatt | Main | Buy | Buy | — | — | $41.40 | -19.38% | 2.06B |
| Sep 9, 2026 | INNV | InnovAge Holding Corp. | Keybanc | Main | Overweight | Overweight | — | — | $6.80 | -35.85% | 724.13M |
| Sep 9, 2026 | IONQ | IonQ, Inc. | Mizuho | Main | Outperform | Outperform | Buy | 16 | $69.60 | +88.93% | 18.61B |
| Sep 9, 2026 | IONQ | IonQ, Inc. | Rosenblatt | Main | Buy | Buy | Buy | 16 | $69.60 | +88.93% | 18.61B |
| Sep 9, 2026 | IONQ | IonQ, Inc. | Cantor Fitzgerald | Reiterated | Overweight | Overweight | Buy | 16 | $69.60 | +88.93% | 18.61B |
| Sep 9, 2026 | IONQ | IonQ, Inc. | Needham | Reiterated | Buy | Buy | Buy | 16 | $69.60 | +88.93% | 18.61B |
